Cargando…
Recombinant Vectors as Influenza Vaccines
The antiquated system used to manufacture the currently licensed inactivated influenza virus vaccines would not be adequate during an influenza virus pandemic. There is currently a search for vaccines that can be developed faster and provide superior, long-lasting immunity to influenza virus as well...
Autores principales: | Kopecky-Bromberg, Sarah A., Palese, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115000/ https://www.ncbi.nlm.nih.gov/pubmed/19768410 http://dx.doi.org/10.1007/978-3-540-92165-3_13 |
Ejemplares similares
-
Making Better Influenza Virus Vaccines?
por: Palese, Peter
Publicado: (2006) -
Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012) -
Recombinant vector vaccine evolution
por: Bull, James J., et al.
Publicado: (2019) -
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015) -
Clinical Advances in Viral-Vectored Influenza Vaccines
por: Sebastian, Sarah, et al.
Publicado: (2018)